EORTC protocol 40901

Phase II study of Navelbine, IV infusion weekly administration, in patients with metastatic epidermoid oesophagial carcinoma
Trial StatusAll trial activities ended
DatesDate of activation: 29-Oct-90
Closed on : 19-Apr-94
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size50
Number of steps1
Drug
Study StaffThierry Conroy (Study Coordinator) - Institut de Cancérologie de Lorraine, Vandoeuvre-Les-Nancy
Type of cancerEsophageal
Participating GroupsEORTC Gastrointestinal Tract Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section